Search
for
Sort by
Research 391–420 of 1000+
- PCOS in adolescents
- Idiopathic Hirsutism*
- The Interrelation Between Hirsutism and Androgen Hormone Levels as Well as Serum TNFΑ Concentrations
- Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span
- Serotoninergic and melatoninergic systems are fully expressed in human skin
- Hair loss and herbs for treatment
- <i>Curcuma aeruginosa</i>, a novel botanically derived 5α-reductase inhibitor in the treatment of male-pattern baldness: a multicenter, randomized, double-blind, placebo-controlled study
- Medication-Induced Repigmentation of Gray Hair: A Systematic Review
- Changes of androgens levels in menopausal women
- 5α-Reductase type 1 inhibition of Oryza sativa bran extract prepared by supercritical carbon dioxide fluid
- Fabrication of polyvinyl pyrrolidone-K90/Eudragit RL100-based dissolving microneedle patches loaded with alpha-arbutin and resveratrol for skin depigmentation
- The role of microneedling in treatment of melasma
- Androgen effects on the skin
- Polycystic Ovarian Syndrome: The Androgenized Adolescent
- Sesquiterpene-Enriched Extract of <i>Curcuma aeruginosa</i> Roxb. Retards Axillary Hair Growth: A Randomised, Placebo-Controlled, Double-Blind Study
- Plant-Produced Basic Fibroblast Growth Factor (bFGF) Promotes Cell Proliferation and Collagen Production
- Review on Diagnostic and Managerial Consequences of PCOS Among Females
- Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism
- The Hirsute Woman: Challenges in Evaluation and Management
- MANAGEMENT OF ENDOCRINE DISEASE Hyperandrogenic states in women: pitfalls in laboratory diagnosis
- Lack of association between clinical and biochemical hyperandrogenism in patients with polycystic ovary syndrome
- In vivo and in vitro exposure to free fatty acids induce increased androgen production in animal models: a potential pathogenic factor of the polycystic ovary syndrome
- Polycystic ovary syndrome
- Skin melanocytes: biology and development
- The cutaneous serotoninergic/melatoninergic system: securing a place under the sun
- Genetic, hormonal and metabolic aspects of PCOS: an update
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- PAK4 signaling in health and disease: defining the PAK4–CREB axis
- The role of lymphocytes in the development and treatment of alopecia areata
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner